Skip to main content
Journal cover image

Non-alcoholic fatty liver diseases and risk of colorectal neoplasia.

Publication ,  Journal Article
Ahn, JS; Sinn, DH; Min, YW; Hong, SN; Kim, HS; Jung, S-H; Gu, S; Rhee, P-L; Paik, SW; Son, HJ; Gwak, G-Y
Published in: Alimentary pharmacology & therapeutics
January 2017

Non-alcoholic fatty liver disease (NAFLD) is associated with colorectal neoplasia. Yet, NAFLD ranges from simple steatosis to steatohepatitis with advanced fibrosis.To investigate the risk of colorectal neoplasia according to the presence and severity of NAFLD.A total of 26 540 asymptomatic adults who underwent same day first-time colonoscopy and abdominal ultrasonography as a health check-up programme were analysed. NAFLD was diagnosed by ultrasonography. Advanced colorectal neoplasia was defined as an invasive cancer or adenoma that was at least 10 mm in diameter, had high-grade dysplasia, or had villous histological characteristics or any combination thereof.NAFLD patients had a higher prevalence of any colorectal neoplasia (38.0% vs. 28.9%) and advanced colorectal neoplasia (2.8% vs. 1.9%) compared to those without NAFLD. In a multivariable model adjusted for age, sex, smoking, alcohol, body mass index, first-degree family history of colorectal cancer, aspirin use and metabolic factors, the odd ratios comparing patients with NAFLD to those without were 1.10 [95% confidence interval (CI): 1.03-1.17] for any colorectal neoplasia and 1.21 (95% CI: 0.99-1.47) for advanced colorectal neoplasia. When NAFLD patients were further stratified according to the non-invasive parameters of liver disease severity, the risk of any colorectal neoplasia or advanced colorectal neoplasia was higher for those with severe liver diseases than those with mild liver diseases.The presence and severity of NAFLD were closely associated with any colorectal neoplasia and advanced colorectal neoplasia, suggesting that clinicians should be aware of the increased risk of colorectal neoplasia in patients with NAFLD.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Alimentary pharmacology & therapeutics

DOI

EISSN

1365-2036

ISSN

0269-2813

Publication Date

January 2017

Volume

45

Issue

2

Start / End Page

345 / 353

Related Subject Headings

  • Ultrasonography
  • Risk Factors
  • Prevalence
  • Odds Ratio
  • Non-alcoholic Fatty Liver Disease
  • Middle Aged
  • Male
  • Humans
  • Gastroenterology & Hepatology
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ahn, J. S., Sinn, D. H., Min, Y. W., Hong, S. N., Kim, H. S., Jung, S.-H., … Gwak, G.-Y. (2017). Non-alcoholic fatty liver diseases and risk of colorectal neoplasia. Alimentary Pharmacology & Therapeutics, 45(2), 345–353. https://doi.org/10.1111/apt.13866
Ahn, J. S., D. H. Sinn, Y. W. Min, S. N. Hong, H. S. Kim, S. -. H. Jung, S. Gu, et al. “Non-alcoholic fatty liver diseases and risk of colorectal neoplasia.Alimentary Pharmacology & Therapeutics 45, no. 2 (January 2017): 345–53. https://doi.org/10.1111/apt.13866.
Ahn JS, Sinn DH, Min YW, Hong SN, Kim HS, Jung S-H, et al. Non-alcoholic fatty liver diseases and risk of colorectal neoplasia. Alimentary pharmacology & therapeutics. 2017 Jan;45(2):345–53.
Ahn, J. S., et al. “Non-alcoholic fatty liver diseases and risk of colorectal neoplasia.Alimentary Pharmacology & Therapeutics, vol. 45, no. 2, Jan. 2017, pp. 345–53. Epmc, doi:10.1111/apt.13866.
Ahn JS, Sinn DH, Min YW, Hong SN, Kim HS, Jung S-H, Gu S, Rhee P-L, Paik SW, Son HJ, Gwak G-Y. Non-alcoholic fatty liver diseases and risk of colorectal neoplasia. Alimentary pharmacology & therapeutics. 2017 Jan;45(2):345–353.
Journal cover image

Published In

Alimentary pharmacology & therapeutics

DOI

EISSN

1365-2036

ISSN

0269-2813

Publication Date

January 2017

Volume

45

Issue

2

Start / End Page

345 / 353

Related Subject Headings

  • Ultrasonography
  • Risk Factors
  • Prevalence
  • Odds Ratio
  • Non-alcoholic Fatty Liver Disease
  • Middle Aged
  • Male
  • Humans
  • Gastroenterology & Hepatology
  • Female